Daniela Cornea is a seasoned finance professional with over a decade of experience, currently serving as a Senior Finance and Business Partner at Novartis. In her role, Daniela plays a pivotal part in the financial planning process, ensuring that the organization’s strategic objectives are met...
Daniela Cornea is a seasoned finance professional with over a decade of experience, currently serving as a Senior Finance and Business Partner at Novartis. In her role, Daniela plays a pivotal part in the financial planning process, ensuring that the organization’s strategic objectives are met through meticulous budgeting, forecasting, and business analysis. Her expertise in financial analysis and corporate financial reporting allows her to provide invaluable insights that drive decision-making for business unit leaders across the company.
Before joining Novartis, Daniela honed her skills in various high-profile roles, starting her career as an auditor at Ernst & Young, where she specialized in the banking, insurance, and leasing sectors. This foundational experience equipped her with a robust understanding of external audit processes and compliance with International Financial Reporting Standards (IFRS). Following her tenure at Ernst & Young, she transitioned to GlaxoSmithKline as a Finance & Reporting Analyst, where she further developed her financial reporting acumen.
At Europharm Holding, Daniela excelled as a Senior Group Credit Controller, where she managed complex financial operations and collaborated cross-functionally to enhance financial performance. Her current position at Novartis allows her to leverage her extensive background in budgeting and financial reporting to support various departments, ensuring alignment with corporate goals. Daniela's commitment to excellence and her ability to foster cross-functional collaborations make her a key contributor to Novartis's financial success, as she continues to drive impactful financial strategies that support the company’s mission in the healthcare industry.
